Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Must-See Attractions in Australia - 2Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide
- 3Some super-smart dogs can pick up new words just by eavesdropping
- 4Cannabis reclassification could 'open the floodgates' for research, scientists say
- 5The Red Sea strategy: What does Israel stand to gain from recognizing Somaliland?
- Blue Origin safely launches wheelchair user to space and back
- Investigate Something else for Less: Financial plan Travel Objections
- Make your choice for a definitive Christmas place to get-away!
- Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- 'Tangled' live-action movie casts Teagan Croft and Milo Manheim as Rapunzel and Flynn
- Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
- Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- Conquering Language Boundaries: Individual Accounts of Multilingualism
